Genocin

Quick links to important sections

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Genocin

Quick Facts

Property Description
Active ingredient Chloroquine (typically Chloroquine phosphate)
Form Oral tablet (primary form), injectable solution
Pharmacological class 4-Aminoquinoline derivative, Antimalarial, Amebicide
General purpose Anti-parasitic action, immunomodulation
Origin Synthetic Small Molecule

What is Genocin and What Pharmacological Class Does it Belong To?

Genocin is a trade name for the synthetic medicinal substance Chloroquine, which is chemically defined as a potent 4-aminoquinoline derivative. This compound is a Small Molecule that major pharmacopeias classify within the essential drug categories of antimalarials and amebicides. Chloroquine, typically supplied as its salt, Chloroquine phosphate, functions as a single-active-ingredient product and is distinguished from newer antimalarials that belong to chemically unrelated classes. Clinical literature confirms that Chloroquine is an established tool for fighting the causative agents of specific protozoal diseases.

Physical Composition and Forms of Genocin

The core composition of Genocin centers on the active substance Chloroquine combined with necessary inactive pharmaceutical excipients. The compound is commonly formulated for systemic delivery, most frequently as an oral tablet—the primary form used for long-term administration and prophylaxis. The structural characteristics of Chloroquine ensure its solubility in aqueous solutions, a necessary property for its effective absorption and distribution throughout the body after oral or parenteral administration. This solubility profile highlights its suitability for versatile administration methods, including the injectable solution form.

Core Purpose: Anti-Parasitic and Immunomodulatory Action

The general therapeutic purpose of Genocin is two-fold: to prevent or suppress infections caused by certain protozoan parasites and to act as an anti-inflammatory agent. Its anti-parasitic function is directed at susceptible organisms responsible for malaria and for treating cases of extraintestinal amebiasis. Furthermore, the drug is known to function as a lysosomotropic agent, meaning it modulates cellular activities in a way that contributes to its secondary benefit: controlling chronic inflammatory responses associated with specific autoimmune diseases. This specialized property is clinically recognized for helping to reduce unwanted immune activity in the body.

Regulatory References

  1. Chloroquine: MedlinePlus Drug Information
  2. Chloroquine: Indications and Mechanism of Action

What side effects are possible with Genocin?

Possible side effects and safety information

The safety profile of Genocin (Chloroquine) is characterized by documented adverse reactions across multiple system-organ classes, as defined in official regulatory labeling. These effects are grouped into common occurrences and serious adverse reactions.

Commonly reported non-serious adverse reactions documented in regulatory sources include headache, dizziness, nausea, vomiting, diarrhea, abdominal cramps, and pruritus (itching).

Serious Adverse Reactions and Organ Toxicity

Official prescribing information highlights the risk of several serious adverse reactions, which are often associated with long-term or high-dosage therapy:

  • Ocular Toxicity: The potential for irreversible retinal damage (retinopathy) is a defining concern. This damage and associated visual disturbances may progress even after treatment is stopped.
  • Cardiac Toxicity: Serious events include cardiomyopathy (heart muscle damage, sometimes fatal) and life-threatening ventricular arrhythmias, such as Torsades de pointes.
  • Neurological/Metabolic Events: Documented serious reactions include convulsions (seizures), acute extrapyramidal disorders, and severe hypoglycemia, which can lead to loss of consciousness.

Safety Considerations for Specific Populations

Safety constraints and increased risk are noted for specific patient groups in official labeling. The pediatric population is especially sensitive to 4-aminoquinoline compounds, and accidental ingestion has been reported to cause fatalities. Use requires caution in patients with pre-existing hepatic disease or alcoholism, and the risk of toxic reactions is considered greater in patients with impaired renal function. Furthermore, use may precipitate or worsen attacks of Psoriasis or Porphyria.

Overdose and Emergency Response

Overdose with Genocin (Chloroquine) is an acute medical emergency due to the rapid onset of life-threatening toxicity. Seek immediate medical attention for any suspected overdose or if experiencing irregular heartbeats, fainting, or severe dizziness during treatment.

Documented Overdose Manifestations

Official regulatory documents indicate that overdose primarily affects the cardiovascular and central nervous systems. Manifestations include significant cardiovascular effects such as QRS and QT interval prolongation, heart block, ventricular arrhythmias, and severe hypotension, which can rapidly progress to cardiac arrest. CNS toxicity is characterized by headaches, agitation, convulsions (seizures), and potentially coma and respiratory arrest. Metabolic disturbances, notably severe hypoglycemia and severe hypokalemia, are also documented complications of acute toxicity.

Regulatory Management and Risks

The official management approach is strictly symptomatic and supportive, as no specific antidote is known. Continuous cardiac monitoring and specific interventions, such as the administration of sodium bicarbonate for managing QRS prolongation, are required in the clinical setting. A critical warning in the regulatory labeling highlights the extreme sensitivity of children, where fatalities have been reported following the accidental ingestion of even relatively small doses. The rapid progression and high fatality risk underscore the mandate to contact emergency services immediately.

Therapeutic Uses of Genocin

Quick Facts: Genocin Therapeutic Domains

  • Targeted Conditions: Management of serious infections caused by susceptible bacteria.
  • Key Areas: Includes applications for conditions such as septicemia (blood infections), meningitis (infections of the membranes surrounding the brain and spinal cord), and severe infections involving the urinary tract, lungs, skin, bones, joints, and abdomen.
  • Scope: Used when other therapeutic options may not be appropriate for the specific bacterial infection.

What Genocin Treats: Main Uses and Benefits

Genocin is a prescription medicine employed in the clinical setting for the management of serious infections that are confirmed or strongly suspected to be caused by certain susceptible bacteria. It is a therapeutic agent that supports the body's response against bacterial proliferation in diverse systems.

Its clinical application primarily addresses severe bacterial infections, including those affecting the circulatory system, such as septicemia. Genocin may also be considered in treatment regimens for infections of the central nervous system, specifically meningitis, as well as complicated infections of the abdomen.

Further approved therapeutic domains include the treatment of serious bacterial infections of the pulmonary system (e.g., pneumonia), the urinary tract, and complex infections involving the skin, soft tissue (including severe burns), bones, and joints.

The therapeutic intent of Genocin is to assist in the control of these serious bacterial infections, contributing to the overall patient stabilization and recovery process. As an antimicrobial agent, Genocin functions by intervening with bacterial growth processes, helping the immune system to resolve the infection.

Regulatory References

  1. NIH MedlinePlus guidance

Eligibility and Restrictions for Use

Who can and cannot use Genocin? (Official Regulatory Information)

Official regulatory documents define eligibility for Genocin (Gentamicin) based on absolute contraindications and mandatory use restrictions. The drug is contraindicated and must not be used by patients with a history of hypersensitivity or serious toxic reactions to Genocin or to any other drug in the aminoglycoside class.


Contraindications and Restrictions

Classification Population/Condition
Absolute Contraindication Hypersensitivity to Genocin or other Aminoglycosides.
Absolute Contraindication Myasthenia gravis or other neuromuscular disorders.
Conditional/Restricted Use Renal Impairment: Requires mandatory dose adjustments and close drug level monitoring.
Conditional/Restricted Use Elderly Patients: Requires caution and close monitoring due to increased risk of toxicity.
Conditional/Restricted Use Pregnancy: Use is generally restricted unless essential, due to potential for fetal harm (e.g., bilateral congenital deafness, based on a related drug).

Age-Related Eligibility: Genocin is generally established for use across the entire age spectrum, from neonates and infants through children, adolescents, and adults. However, use in neonates and the elderly is subject to specific dosing and heightened monitoring protocols due to known physiological differences in drug clearance.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The Genocin interaction profile is characterized by several officially documented pharmacokinetic and pharmacodynamic constraints. Co-administration with Cimetidine is advised to be avoided, as this substance inhibits Genocin's metabolism, resulting in a significant increase in Genocin plasma levels (higher exposure). Conversely, substances such as Antacids and Kaolin must be administered with a separation of at least 4 hours from Genocin, as they reduce the drug’s absorption.

Pharmacodynamic interactions often involve additive risk. Concomitant use with drugs that prolong the QT interval (e.g., certain antibiotics or antiarrhythmics) increases the risk of ventricular arrhythmias. Similarly, co-administration with Mefloquine increases the documented risk of convulsions. Genocin may also enhance the effect of anti-diabetic drugs, potentially leading to severe hypoglycemia.

Specific restrictions apply to other compounds: Genocin can increase serum Cyclosporine levels, and it significantly reduces the bioavailability of oral Ampicillin, which requires a mandatory 2-hour separation of doses. Caution is also advised in patients with impaired renal function due to a greater risk of toxic reactions resulting from reduced clearance.

Mechanism of Action

How Genocin Works: Pharmacodynamic Mechanisms

Genocin (Chloroquine) acts through two distinct mechanistic domains, both reliant on its nature as a weak base and its property of lysosomotropism, which causes selective accumulation in acidic cellular compartments.


Inhibition of Parasite Detoxification System

This domain targets susceptible parasites by concentrating in the acidic food vacuole. The drug acts as an inhibitor by blocking the conversion of toxic Ferriprotoporphyrin IX (FP) into nontoxic hemozoin. This targeted action causes the accumulation of the toxic FP-Chloroquine complex, resulting in the disruption of parasite cellular integrity and cell lysis.


️ Endosomal pH Modulation in Host Immune Cells

In host physiology, the drug modulates immune activity by accumulating in and raising the pH of acidic intracellular compartments (endosomes/lysosomes) within immune cells. This pH change suppresses the acid-dependent activation of Toll-like Receptors ( TLRs) and impairs antigen processing. This interference with key signaling steps results in the suppression of pro-inflammatory cytokine release and the alteration of host immune signaling.

Dosage and Administration Information

Official Administration Guidelines for Genocin

Genocin (chloroquine phosphate) is taken orally in tablet form. Dosing is often expressed in terms of the equivalent chloroquine base; for example, a 500 mg tablet of chloroquine phosphate is equal to 300 mg of base. The administration regimen varies strictly by the medical use.


Dosing and Schedule Protocols

Use Case Adult Dosage and Schedule Pediatric Dosing Rule
Malaria Prophylaxis 300 mg base (500 mg salt) once weekly on the same day. Starts 1–2 weeks before exposure and continues for 4 to 8 weeks after leaving the endemic area. 5 mg base per kg of body weight once weekly, not to exceed the adult dose.
Acute Malaria Treatment Total 1.5 g base (2.5 g salt) administered over 3 days. A loading dose of 600 mg base is given initially, followed by doses at 6-8 hours, 24 hours, and 48 hours. Calculated as 10 mg base/kg for the first dose, then 5 mg base/kg for the next three doses, not to exceed the adult maximums.
Extraintestinal Amebiasis 600 mg base daily for the first two days, followed by 300 mg base daily for at least 2 to 3 weeks. Dosing must be determined by the prescriber based on body weight.

Administration Conditions

Tablets should be taken with food to help reduce potential gastrointestinal upset. For optimal absorption, the drug must be administered at least 4 hours apart from antacids or kaolin. For certain types of malaria, administration requires concomitant use of an 8-aminoquinoline compound to ensure complete parasite elimination. Adherence to the scheduled timing, particularly taking weekly doses on the same day, is critical for maintaining therapeutic levels.

Recent Clinical Evidence

Research Evidence / Overview of Studies

Research has investigated the effects on joint health and has examined the association with changes in joint discomfort related to mild osteoarthritis. The dual-action combination was also studied for outcomes related to joint discomfort over time. Research has documented the timeline for potential initial changes, including observations within 2–4 weeks. Studies have assessed measures following research administration for a period of at least 12 weeks.


Research Focus on Biochemical Markers

Research focused on analyzing inflammatory markers in the synovial fluid and included analysis of the overall viscosity of the joint fluid.


Clinical Trial Summaries

Study 1: Initial Assessment (6-Week Duration)

A study of 120 adults with mild to moderate knee pain examined the effects of the combination compared to placebo, using measures of discomfort. The research protocol involved participants taking the combination for 6 weeks. The primary focus of the analysis was on the participants' self-reported discomfort levels (using a standardized scale) at the end of the 6-week period. Findings also indicated that the combination was administered alongside Glucosamine-only treatments in the study for comparative assessment.

Study 2: Sustained Assessment and Research Dosing (12-Week Duration)

This larger, follow-up study examined the combination over a 12-week period with 250 participants. The study examined different research concentrations of the combination to assess outcome measures. Researchers utilized a dosage of 2 g daily in the study protocol to assess specific outcomes, and was a concentration that was included in the research assessment. The research did not extend to populations with symptoms beyond those studied in this research (mild to moderate osteoarthritis symptoms).

Key Studies & References Guidance for the Clinical Use of Slow-Acting Agents in Osteoarthritis Management (National Rheumatology Society)

Frequently Asked Questions (FAQ)

Common questions about Genocin (FAQ)

Q: How quickly should I expect to feel a difference after starting Genocin?

A: Studies and official information indicate that the timeline for feeling a difference varies based on the reason for use. Research observations related to its immunomodulatory uses have been documented within 2–4 weeks. However, the time it takes for Genocin to act for parasitic infections will differ based on the specific infection and the official dosing regimen.

Q: How long does Genocin stay in your system?

A: Official pharmacokinetic data describes how the drug moves through the body, indicating that Genocin's terminal half-life can range from approximately 40 to 50 days. This long half-life means the active compound remains detectable in the body for an extended period after the last dose is taken.

Q: Can Genocin be used by older adults?

A: Official information states that use in older adults is generally established. However, this is described as a conditional use that requires caution and close monitoring. This is due to known physiological differences in drug clearance, which may lead to a greater risk of toxic reactions.

Q: Is Genocin appropriate for children?

A: Genocin is established for use across the pediatric age range. However, children are especially sensitive to this class of compounds. Accidental ingestion in children has been associated with fatalities, which is why official information stresses the need for heightened monitoring and safe storage.

Q: What if I take too much Genocin accidentally?

A: Official regulatory documents describe an overdose of Genocin as a medical emergency that can be fatal and is associated with serious cardiovascular and neurological toxicity. Due to the severity of the documented risks, immediate emergency medical assessment is critical in the event of a suspected overdose.

Q: Is it okay to take Genocin with vitamins or herbal supplements?

A: Official documents detail specific interactions with certain medications and antacids. However, there is no general descriptive statement provided regarding common vitamins or most herbal supplements. Any potential interactions should be reviewed with a healthcare professional before use.

Q: Does Genocin treat the root cause, or just the symptoms?

A: Genocin's action varies by indication. For parasitic diseases, the mechanism involves the direct disruption of the parasite's cellular integrity, addressing the cause of the infection. For its other use in autoimmune conditions, it works to modulate specific immune activities to suppress pro-inflammatory responses, which treats the symptoms.

Q: Is Genocin safe to take long-term?

A: Regulatory documents indicate that long-term, high-dosage therapy is officially associated with the risk of several serious adverse reactions. These include the potential for irreversible retinal damage and cardiac toxicity. Regular and ongoing medical monitoring is necessary, as directed by official guidance, if prolonged use is being considered.

Q: Can Genocin be taken on an empty stomach?

A: Official administration conditions advise taking Genocin tablets with food to help reduce the potential for gastrointestinal upset such as nausea or stomach pain. Following the official guidance to take it with food is consistent with efforts to help minimize gastrointestinal side effects.

Q: Why do some people say Genocin didn't work for them?

A: Official warnings note that Genocin is not effective against chloroquine-resistant strains of certain parasites. In such cases, the person may not respond to adequate doses, and such an outcome would need to be reviewed by a healthcare professional to determine if a change in therapy is warranted.

Q: Are there different strengths of Genocin?

A: Yes, Genocin is officially available in different tablet strengths. The dosage is often expressed in terms of the chloroquine base, with common strengths being 250 mg and 500 mg of the salt, which are equivalent to different amounts of the active base.

Q: Does Genocin affect mood or cause anxiety?

A: Regulatory bodies have reviewed data linking the use of Genocin to the risk of psychiatric disorders. Reported adverse reactions in official documents include anxiety, confusion, hallucinations, and in rare cases, suicidal behavior.

Q: Is Genocin addictive?

A: No, Genocin's active ingredient, chloroquine, is not classified as a controlled substance under the US Drug Enforcement Administration (DEA) schedules. This indicates it does not carry a formal designation for dependence or abuse potential.

Q: If my symptoms feel better, should I keep taking Genocin?

A: For parasitic diseases, official guidelines stress the importance of continuing the treatment for the full prescribed time. Official guidelines emphasize that stopping the medication early may be associated with the infection not being fully cleared, which could potentially increase the risk of developing drug resistance.

Q: Do you need a special kind of prescription to get Genocin?

A: Genocin is an established drug that requires a valid prescription for dispensing. It is a prescription-only medication but is not typically listed as a Federally controlled substance in the US.

Q: Can Genocin be split or crushed?

A: Official instructions generally advise swallowing the tablet whole. Breaking or crushing tablets should be avoided unless the tablet is officially scored (designed to be broken). Specific advice regarding breaking or crushing tablets should be confirmed with a healthcare provider or pharmacist, even if the tablet is scored.

Q: What does official research evidence say about Genocin's long-term results?

A: Official research evidence includes study periods of up to 12 weeks for certain uses. Long-term results over many years are primarily addressed through safety monitoring. This monitoring focuses on the documented risk of ocular and cardiac toxicity associated with prolonged use.

Q: Why is Genocin taken [once/twice] a day?

A: The specific timing and frequency are determined by the medical use and the drug’s properties. For prevention (prophylaxis), it is taken weekly to maintain continuous therapeutic levels. For acute treatment, it is taken in a series of doses over a few days to achieve a necessary initial high dose to fight the infection.

Q: Are Genocin's effects permanent or only while you take the medicine?

A: For parasitic infections, the drug's goal is to eliminate the organisms, which should resolve the illness. For its immunomodulatory effects in other conditions, the intended action of suppressing specific cellular activities is generally sustained only while the medicine is being taken.

Q: Can I use Genocin if I am trying to conceive?

A: Official regulatory documents address use during a confirmed pregnancy, noting that this drug crosses the placenta. Reviewing this concern with a healthcare professional is important, as information specific to the pre-conception phase is not standardized in official labels.

Q: Is it true that Genocin can cause changes to skin or hair?

A: Yes, regulatory documents list changes to skin and hair as possible adverse reactions. These effects may include changes in hair color, hair loss, increased sensitivity of the skin to sunlight, and various forms of skin discoloration.

Q: How is Genocin metabolized by the body?

A: Official pharmacokinetic information states that Genocin undergoes degradation, primarily in the liver, by cytochrome P450 enzymes. This process results in the formation of desethylchloroquine, which is a substance that is also pharmacologically active.

Q: Is Genocin used to prevent future illness, or just to treat current symptoms?

A: Genocin is officially used for both purposes, depending on the indication. It is used for prophylaxis (prevention of malaria) and for the treatment of acute malaria and extraintestinal amebiasis.

How should Genocin be stored and disposed of?

How to Store and Dispose of Genocin (Gentamicin)

Official regulatory information specifies the precise conditions under which Genocin must be stored and handled to maintain its stability.

Storage Requirements

Storage Factor Official Requirement
Temperature Store at Controlled Room Temperature (20°C to 25°C).
Prohibitions Do not freeze. Do not store above 25°C.
Protection Keep in the original container to protect from light.
After Opening Use immediately. If not used, discard any remaining portion after 24 hours (if refrigerated).
Safety Keep the medicine out of the reach of children.

Disposal Instructions

Unused or expired Genocin must be disposed of according to local pharmaceutical waste regulations. It is officially required to avoid disposal via household waste or wastewater to prevent release into the environment.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Genocin found in:

A-Z Index: